BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20531011)

  • 1. Comparison of olanzapine and risperidone in the EMBLEM Study: translation of randomized controlled trial findings into clinical practice.
    Novick D; Reed C; Haro JM; Gonzalez-Pinto A; Perrin E; Aguado J; Tohen M
    Int Clin Psychopharmacol; 2010 Sep; 25(5):257-63. PubMed ID: 20531011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial.
    Perlis RH; Baker RW; Zarate CA; Brown EB; Schuh LM; Jamal HH; Tohen M
    J Clin Psychiatry; 2006 Nov; 67(11):1747-53. PubMed ID: 17196055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study.
    Vieta E; Panicali F; Goetz I; Reed C; Comes M; Tohen M;
    J Affect Disord; 2008 Feb; 106(1-2):63-72. PubMed ID: 17582508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    McIntyre RS; Mancini DA; Srinivasan J; McCann S; Konarski JZ; Kennedy SH
    Can J Clin Pharmacol; 2004; 11(2):e218-26. PubMed ID: 15520475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of olanzapine monotherapy and olanzapine combination treatment in the long term following acute mania--results of a two year observational study in bipolar disorder (EMBLEM).
    Gonzalez-Pinto A; Vieta E; Reed C; Novick D; Barraco A; Aguado J; Haro JM
    J Affect Disord; 2011 Jun; 131(1-3):320-9. PubMed ID: 21195486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translation of randomised controlled trial findings into clinical practice: comparison of olanzapine and valproate in the EMBLEM study.
    Novick D; Gonzalez-Pinto A; Haro JM; Bertsch J; Reed C; Perrin E; Tohen M;
    Pharmacopsychiatry; 2009 Jul; 42(4):145-52. PubMed ID: 19585393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.
    Suppes T; Brown E; Schuh LM; Baker RW; Tohen M
    J Affect Disord; 2005 Dec; 89(1-3):69-77. PubMed ID: 16253344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
    Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S
    J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone in the treatment of mixed state bipolar patients: results from a 24-week, multicenter, open-label study in Korea.
    Woo YS; Bahk WM; Jon DI; Chung SK; Lee SY; Ahn YM; Pae CU; Cho HS; Kim JG; Hwang TY; Lee HS; Min KJ; Lee KU; Yoon BH
    Psychiatry Clin Neurosci; 2010 Feb; 64(1):28-37. PubMed ID: 19895394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children.
    Biederman J; Mick E; Hammerness P; Harpold T; Aleardi M; Dougherty M; Wozniak J
    Biol Psychiatry; 2005 Oct; 58(7):589-94. PubMed ID: 16239162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial.
    Hirschfeld RM; Keck PE; Kramer M; Karcher K; Canuso C; Eerdekens M; Grossman F
    Am J Psychiatry; 2004 Jun; 161(6):1057-65. PubMed ID: 15169694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
    Vieta E; Angst J; Reed C; Bertsch J; Haro JM;
    J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder.
    Wozniak J; Mick E; Waxmonsky J; Kotarski M; Hantsoo L; Biederman J
    J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):539-45. PubMed ID: 19877978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania.
    Ouyang WC; Hsu MC; Yeh IN; Kuo CC
    Int J Psychiatry Clin Pract; 2012 Sep; 16(3):178-88. PubMed ID: 22404731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of early improvement to predict response or remission in acute mania: focus on olanzapine and risperidone.
    Kemp DE; Johnson E; Wang WV; Tohen M; Calabrese JR
    J Clin Psychiatry; 2011 Sep; 72(9):1236-41. PubMed ID: 21457677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
    Vieta E; Herraiz M; Fernández A; Gastó C; Benabarre A; Colom F; Martínez-Arán A; Reinares M
    J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
    Tohen M; Greil W; Calabrese JR; Sachs GS; Yatham LN; Oerlinghausen BM; Koukopoulos A; Cassano GB; Grunze H; Licht RW; Dell'Osso L; Evans AR; Risser R; Baker RW; Crane H; Dossenbach MR; Bowden CL
    Am J Psychiatry; 2005 Jul; 162(7):1281-90. PubMed ID: 15994710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute phase results from STORM, a multicountry observational study of bipolar disorder treatment and outcomes.
    Treuer T; Oruc L; Loza N; El Saidi MA; Kovacs Z; Akkaya C; Gülseren S; Saylan M; Colman SA; Harrison GA
    Psychiatr Danub; 2007 Dec; 19(4):282-95. PubMed ID: 18000479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.